Have you ever thought about how amazing it would be to be able to detect colon cancer with just a blood test? Well, that time has come! Let us introduce you to PreveCol®, a revolutionary test that is transforming the early diagnosis of colorectal cancer. Let’s see below all the details of this medical innovation that could save many lives.
What is PreveCol® and how does it work?
PreveCol® is not typical colon cancer test; It is a next-generation test that combines artificial intelligence with the analysis of biomarkers present in blood plasma for the early detection of colorectal cancer (CRC) and advanced adenomas (AA), offering a non-invasive and effective alternative to conventional methods. traditional.
The operation of PreveCol® is based on a sophisticated algorithm that integrates multiple elements. First, it analyzes a series of specific biomarkers present in a patient’s blood sample. These biomarkers include proteins and micro-RNAs that can indicate the presence of CRC or AA.
Additionally, the algorithm takes into account clinical risk factors and personal characteristics of the patient, such as age, to provide a more precise and personalized result.
The process of performing the test is simple and comfortable for the patient. Unlike colonoscopy, PreveCol® does not require any prior bowel preparation or sedation. It is only necessary to take a small blood sample and send it to the laboratory for analysis.
Benefits of PreveCol®
Early and accurate detection
One of the most significant advantages of PreveCol® is its ability to detect signs of colorectal cancer even years before the tumor forms. This is possible thanks to its ability to identify intestinal polyps, which are precursors to cancer.
Therefore, by detecting these precancerous lesions, PreveCol® allows early intervention, significantly increasing the chances of prevention and cure of colorectal cancer.
Non-invasive and convenient method
Unlike other screening methods, PreveCol® is a blood-based test, making it easy and non-invasive. This means that patients can undergo the test without having to go through more complicated or uncomfortable procedures.
Greater diagnostic efficiency
PreveCol® has been shown to have better diagnostic efficacy than currently approved colorectal cancer screening tests. This increased accuracy can lead to a reduction in false positives and negatives, resulting in a more reliable diagnosis.
The importance of early detection of colon cancer
Detecting colon cancer early is crucial; It can make the difference between overcoming the disease or facing much more serious consequences. This type of cancer affects millions of people around the world and, unfortunately, is one of the main causes of death from this disease. But there is good news: if identified in early stages, the five-year survival chances skyrocket to a promising 90%.
And this is where PreveCol® changes the rules of the game. This innovative method allows warning signs to be detected even before the first symptoms appear. What does this mean? That doctors can act quickly, using less invasive treatments with greater chances of success.
A step forward in the fight against colorectal cancer
As you can see, PreveCol® is revolutionizing the way we detect colon cancer early, offering a comfortable, precise and non-invasive alternative to conventional methods. So, the next time you visit your doctor, don’t forget to ask about PreveCol®. It can be the simplest and most decisive step to take care of your health.
Add Comment